GEM Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$974K Sell
812
-12
-1% -$12.3K 0.38% 44
2026
Q1
$758K Sell
824
-6
-0.7% -$6.08K 0.33% 45
2025
Q4
$920K Sell
830
-18
-2% -$17.2K 0.41% 43
2025
Q3
$716K Sell
848
-6
-0.7% -$4.46K 0.34% 44
2025
Q2
$660K Sell
854
-57
-6% -$44.3K 0.34% 45
2025
Q1
$734K Sell
911
-66
-7% -$54.9K 0.41% 41
2024
Q4
$754K Sell
977
-56
-5% -$46.4K 0.42% 40
2024
Q3
$928K Hold
1,033
0.53% 34
2024
Q2
$935K Sell
1,033
-25
-2% -$20K 0.58% 32
2024
Q1
$794K Hold
1,058
0.53% 33
2023
Q4
$616K Buy
1,058
+1
+0.1% +$584 0.43% 35
2023
Q3
$568K Hold
1,057
0.45% 35
2023
Q2
$496K Hold
1,057
0.38% 35
2023
Q1
$363K Hold
1,057
0.29% 46
2022
Q4
$387K Buy
+1,057
New +$375K 0.33% 44

Other funds holding LLY

GEM Asset Management's LLY Position: Q2 2026 in Review

GEM Asset Management reduced its Eli Lilly (LLY) stake by 1.5% in Q2 2026, selling an estimated $12.3K and leaving 812 shares worth $974K. The position accounts for 0.38% of the portfolio, ranked #44.

GEM Asset Management first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 1,102 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • GEM Asset Management held 812 shares of Eli Lilly worth $974K as of Q2 2026.
  • GEM Asset Management sold 12 Eli Lilly shares in Q2 2026, an estimated $12.3K.
  • Eli Lilly made up 0.38% of GEM Asset Management's portfolio in Q2 2026, its #44 holding.
  • GEM Asset Management first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 1,102 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on GEM Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.